We are live on ! Find out more
ACIU icon

AC Immune
ACIU

15 hedge funds and large institutions have $102M invested in AC Immune in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.52% less ownership

Funds ownership: 19.67% → 19.15% (-0.52%)

12% less capital invested

Capital invested by funds: $117M → $102M (-$14.4M)

17% less funds holding

Funds holding: 18 → 15 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
15
Holders Change
-3
Holders Change %
-16.67%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity International
Fidelity International
Bermuda
+$12.7M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$258K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$61.9K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.2M
2
Renaissance Technologies
Renaissance Technologies
New York
-$563K
3
Deutsche Bank
Deutsche Bank
Germany
-$462K
4
Morgan Stanley
Morgan Stanley
New York
-$328K
5
Citadel Advisors
Citadel Advisors
Florida
-$163K

ACIU Hedge Fund Activity: Q2 2018 in Review

15 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q2 2018, worth a combined $102M — down 12% from $117M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ACIU and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Fidelity International, opening a new position worth an estimated $12.7M. The largest seller was Fidelity Investments, cutting an estimated $14.2M.

  • 15 institutional investors held AC Immune (ACIU) as of Q2 2018, down from 18 in Q1 2018.
  • Funds reported $102M of AC Immune stock for Q2 2018, down 12% quarter-over-quarter.
  • 2 funds opened new AC Immune positions in Q2 2018 and 5 closed out, a net change of -3 holders.
  • The largest AC Immune buyer in Q2 2018 was Fidelity International, an estimated $12.7M added.
  • The largest AC Immune seller in Q2 2018 was Fidelity Investments, an estimated $14.2M sold.

Based on aggregated 13F filings for Q2 2018.